Analysis of clinical outcomes according to response status in prospective clinical trials of atezolizumab (atezo) in pretreated locally advanced/metastatic urothelial carcinoma (mUC).Jens Bedke,Axel Stuart Merseburger,Yohann Loriot,Daniel Castellano,Ernest Choy,Ignacio Duran,Jonathan E. Rosenberg,Daniel Peter Petrylak,Robert Dreicer,Jose Luis Perez-Gracia,Jean H. Hoffman-Censits,Michiel Simon Van Der Heijden,Viraj Degaonkar,Lars Thiebach,Sabine de Ducla,Simon Fear,Thomas Powles,Cora N. SternbergONCOLOGY RESEARCH AND TREATMENT(2020)引用 0|浏览91暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要